Exchange: NYSE·Updated 04:00 PM EDT
News
all
press releases
SNN Advances Surgical Robotics Through Imperial College Partnership
Smith+Nephew's five-year Imperial College London partnership targets less invasive robotic surgery and could speed research into clinical use.
Zacks
More News
Smith+Nephew Launches FLOW FLEXTEND COBLATION Wand for Hip Surgery
SNN launches the FLOW FLEXTEND COBLATION Wand, offering adjustable-angle access and precise tissue removal in complex joint procedures.
Zacks
Smith & Nephew (SNN) Q2 2026 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
Smith+Nephew Expands ASC Platform to Support Value-Based Care
SNN expands ASC Solutions with an integrated platform, analytics and partners to boost efficiency, growth and patient outcomes in outpatient care.
Zacks
Smith+Nephew Launches LYNX COBLATION Wand for ENT Airway Surgery
SNN launches the LYNX COBLATION Laryngeal Wand, combining precise dissection, rapid debulking and hemostasis for airway procedures.
Zacks
VEEV Boosts MedTech Quality Management With Smith+Nephew Partnership
Veeva Systems expands its medtech reach as Smith+Nephew adopts Veeva Quality Cloud to modernize global quality operations and training.
Zacks
Smith & Nephew To Repurchase Up To $250 Mln Of Shares
false
Nasdaq News: Markets
SNN vs. BSX: Which Stock Is the Better Value Option?
SNN vs. BSX: Which Stock Is the Better Value Option?
Zacks
Smith & Nephew (LON:SN) Given Neutral Rating at UBS Group
UBS Group restated a 'neutral' rating and issued a GBX 1,300 price objective on shares of Smith & Nephew in a research report on Tuesday...
MarketBeat
Smith & Nephew (LON:SN) Earns "Hold" Rating from Berenberg Bank
Berenberg Bank reaffirmed a "hold" rating and set a GBX 13 price objective on shares of Smith & Nephew in a research report on Friday...
MarketBeat

Advertisement|Remove ads.